FDA Investigator Dr. Zhou Chen (nmi), MD PhD

Dr. Zhou Chen (nmi), MD PhD has inspections in 6 countries as of 14 Sep 2023. Dr. Zhou Chen (nmi), MD PhD has collaborated with a combinined 5516 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
57
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada, China, India, Taiwan
Co-Investigator(s):
Alan M Barker, Alberto A Viciedo, Alicia M Mozzachio, Allen Lou, Amanda E Lewin, PhD, Amber G Chung, Amber G Wardwell, Amy L Singer, Ana P Barido, Ana S Cabrera, Andrea A Branche, Andrew J Lang, Andrew M Barlow, Andrew R Wasko, Andrew W Harmon, Andria L Kuhlman, Angel K Sandhu, Anh M Lac, Ann Marie Montemurro, Anna M Brannen, Arindam Dasgupta, PhD, Ashar P Parikh, Audria L Kuhlman, Barbar J Breithaupt, Barbara A Rusin, Barbara J Holladay, Barbara J Rincon, Barbara Janine Breithaupt, Barbara L Rellahan, PhD, Betsy C Galliher, Betty K Baxter, Brandon L Mariner, Bruce H Mccullough, Byron Ho, DVM, Byungja E Marciante, Candace Y Gomez Broughton, Cara M Minelli, Carl A Anderson, Carl Lee, Carla C Tuite, Carla R Hinz, Carmen Y Fisher, Carol Mrivera Lopez, PhD, Carolyn A Renshaw, CDR Rochelle B Young, RPh, MSA, Chaltu N Wakijra, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Cote, RIC, Chase Bourke, PhD, Chery Grandinetti, Ching Jeyg Chang, Christian D Lynch (CDL), Christine M Smith, Christine Mwhitby Smith, Christopher T Middendorf, Clinton D Priestley, Connie P Rezendes, Corey K Reno, Corey Reno, Courtney N Long, Craig T Rybus, Ct Viswanathan, PhD, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Da Lin Yao, MD, PhD, Daniel J Grabicki, Daniel Pst Laurent, Daniel R Azar, Darin S Wiegers, David K Glasgow, David L Chon, David P Vanhouten, Dawn C Olenjack, Deborah B Nixon, Debra Bower, Debra I Love, Debra L Boyd Seale, Dell S Moller, Denise L Burosh, Dina A Tallman, Donald B Mckechnie, Douglas A Campbell, Douglas C Kovacs, Douglas Fiorentino Lcdr, Douglas Florentino, Douglas W Gronski, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dustin P Tran, Dylan D Yao, MD, PhD, Edward D Haris, Edward D Harris, Edward D Vains, Eias A Zahalka, Eileen A Liu, Emest F Bizjak, Emmanuel Adu Gyamfi, Eric J Cunningham, Eric Rothschild, Eric S Pittman, Erin D Mccaffery, Erin L Mcfiren, Erin M Mcdowell, Erin Mcdowell, Farhana Khan, Francis J Eng, Franois J Eng, Frederick M Lochner, Gajendiran Mahadevan, PhD, Gary J Hagan, Gary S Hagan, Geoffrey K Kilili, Gloria A Milster, Grace P Santos, Greg K Keshishyan, Gregory W Smith, Gwyn G Dickinson, Hanna L Potter, Heika R Bounds, Heika R Tait, Helen B Ricalde, Helen Verdel, Henry K Lau, High M Mcclure, III, Himanshu Gupta, PhD, Hugh M Mcclure, II, Humberto Z Gomez, Hung H Do, MS, Hyojong Kwon, PhD, Isaiah D Isakson, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, Jane M Kreis, Janet L Bowen, Janete F Guardia, Jasjeet K Sekhon, Jazmine N Still, Jean M Kelahan, Jeanne J Thai, Jeffrey M Watson, Jennifer C Adams, Jennifer L Jager, Jesse A Vazquez, Joanne M Schlossin, Jogy George, Johann M Fitch, John A Kadavil, PhD, Jolanna A Norton, Jonathan R Campos, Jose M Cayuela, Joseph A Piechocki, Joseph F Mcginnis, RPh, Joseph P Iser, MD, Joseph R Haynes, Joslyn K Brunelle, PhD, Joy Rkozlowski Klena, Julian C Hanson, Julie D Bringger, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Karen E D'orazio, Karen M Kondas, Kathleen B Swat, Kathryn A Krentz, Ke Zhang, Kelli F Dobilas, Kelli N Hicks, Kellia N Hicks, Kenneth Nieves, Kent A Conforti, Kent C Faul, Kevin P Foley, Kula N Jha, Kurt A Brorson, PhD, Laine P Myers, Lakisha M Williams, Lance M De Souza, MBA, Laura Fontan, MS, Lauren N Howard, LCDR Jennifer H Rhyu, Lequita M Mayhew, Li Hongpaul Yeh, PhD, Li Li, Liatte Kreuger, PharmD, Linda S Leja, Lori J Silverstein, Luann Mckinney, Lynette P Salisbury, Marcia A Worley, Marcus F Yambot, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Martin J Guardia, Martin K Yau, PhD, Mary E Storch, Mary Jeanet Mcgarry, Matthew C Watson, Melba T Rivera, Melba Trivera Clavell, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael J Nerz, Michael Serrano, Michele Perry Williams, Mike M Rashti, Muralidhara B Gavini, PhD, Nancy A Bellamy, Nancy L Neiger, Nancy L Rolli, Natalie A Mickelsen, DVM, Nathan R Moon, Nebil A Oumer, Nicholas P Diorio, Nicholas Z Lu, Nicole S Williams, Niraj Mehta, Niraj R Mehir, Niraj R Mehta, PhD, Norman K Starks, Nutan Mytle, Paul L Bellamy, Paula A Trost, Peter R Lenahan, Philip J Snoy, Phillip M Pontikos, Prabhu P Raju, Rachel C Harrington, Rafael Padilla, Raymond T Oji, Rebecca T Davis, Regina T Brown, Richard Heath Coats, Richard W Berning, Robert J Ham, Robert J Martin, Robert L Hummel, Ronald R Ruff, Rory K Geyer, Rosanna M Goodrich, Rose Ljean Mary, Rose M Ashley, Ruth A Williams, Sandra A Hughes, Sandra Kershaw, Sandra S Saniga, Sarah Adella Fave, Scott B Laufenberg, Scott B Lausanberg, Scott B Loufoubery, Shalonda C Clifford, Sherri J Jackson, Sherry L Secrist, BLT DO, Shirley H Isbill, Sidney B Priesmeyer, Sinai Davis, Sony Mathews, Sripal R Mada, PhD, Stacey A Priest, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen J Kilker, Stephen K Kilker, Steven P Donald, Stuart W Russell, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan M Jackson, Susan Yuscius, Susanne M Richardson, MSc RAC ELS, Susanne Mrichardsonmsc Rac, Teena H Aiken, Tenzin Jangchup, Thea C Grome, Theressa B Smith, Thomas J Arista, Thomas R Withers, Thomas W Nojek, Thunder N Dunkijacobs, Toyin B Oladimeji, Tracey Asinjen Wiersma, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vickie J Kanion, Victor J Gangi, Victoria M Daddeo, Vlada Matusovsky, Wayne J Meyer, William D Tingley, William V Millar, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Young M Yoon, Yuanyuan Li, Yvette Mlacour Davis, Zhongren Wu

Dr. Zhou Chen (nmi), MD PhD's Documents

Publish Date Document Type Title
August, 2019 FDA 483 Response Bioreliance Corporation - Form 483R, 2019-08-08
August, 2009 FDA 483 Frontage Laboratories, Inc. - Form 483, 2009-08-14
July, 2013 FDA 483 Charles River Laboratories, Inc. - Form 483, 2013-07-12
August, 2009 EIR Frontage Laboratories, Inc. - EIR, 2009-08-14
September, 2017 EIR Shanghai Medicilon Inc. - EIR, 2017-09-15
September, 2019 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2019-09-13
August, 2019 EIR Bioreliance Corporation - EIR, 2019-08-08
September, 2012 FDA 483 Korea Institute of Toxicology - Form 483, 2012-09-26
January, 2015 EIR U.S. Army Medical Research Institute of Infectious Diseases - EIR, 2015-01-21
October, 2016 EIR Amphastar Laboratories Inc - EIR, 2016-10-21
June, 2009 EIR Merck & Company, Inc. - EIR, 2009-06-05
June, 2018 EIR Q2 Solutions - EIR, 2018-06-29
July, 2017 FDA 483 Labcorp Bedford LLC. - Form 483, 2017-07-21
September, 2013 FDA 483 Joinn Laboratories Co. Ltd. - Form 483, 2013-09-20
April, 2017 FDA 483 National Beijing Center For Drug Safety Evaluation And Resea - Form 483, 2017-04-28
April, 2016 EIR Labcorp Bedford LLC. - EIR, 2016-04-29
April, 2017 FDA 483 West China-Frontier Pharma Tech Co., Ltd. - Form 483, 2017-04-21
August, 2010 EIR Merck & Company, Inc. - EIR, 2010-08-20
January, 2015 FDA 483 U.S. Army Medical Research Institute of Infectious Diseases - Form 483, 2015-01-21
May, 2013 EIR Hoffmann La Roche Inc - EIR, 2013-05-09
June, 2018 FDA 483 Charles River Laboratories, Inc - Form 483, 2018-06-15
February, 2011 EIR Bioreliance Corporation - EIR, 2011-02-04
September, 2011 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2011-09-27
October, 2014 FDA 483 Charles River Laboratories - Form 483, 2014-10-10
December, 2011 FDA 483 Battelle Memorial Institute - Form 483, 2011-12-22
August, 2016 FDA 483 JOINN Laboratories (Suzhou) - Form 483, 2016-08-12
August, 2019 FDA 483 Bioreliance Corporation - Form 483, 2019-08-08
February, 2012 FDA 483 SRI International - Form 483, 2012-02-17
November, 2009 EIR Altasciences Preclinical Seattle, LLC - EIR, 2009-11-20
November, 2013 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2013-11-22
October, 2016 FDA 483 Amphastar Laboratories Inc - Form 483, 2016-10-21
March, 2010 EIR Charles River Laboratories, Inc. - EIR, 2010-03-03
April, 2016 FDA 483 Labcorp Bedford LLC. - Form 483, 2016-04-29
February, 2011 FDA 483 Bioreliance Corporation - Form 483, 2011-02-04
October, 2012 EIR Battelle Memorial Institute - EIR, 2012-10-17
July, 2015 FDA 483 Response Covance Pharmaceutical R&D (Shanghai) Co - Form 483R, 2015-08-06
November, 2018 EIR BioMarin Pharmaceutical Inc. - EIR, 2018-11-09
June, 2014 FDA 483 Wuxi Apptec Suzhou Co.,Ltd - Form 483, 2014-06-13
September, 2013 FDA 483 Pharmaron - Form 483, 2013-09-13
October, 2009 FDA 483 Charles River Laboratories, Inc - Form 483, 2009-10-23
November, 2009 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2009-11-20
September, 2014 FDA 483 AbbVie Inc. - Form 483, 2014-09-12
November, 2019 EIR Battelle Memorial Institute - EIR, 2019-11-08
July, 2010 EIR Charles River Laboratories Cleveland, Inc. - EIR, 2010-07-16
February, 2020 FDA 483 U.S. Army Medical Research Institute of Infectious Diseases - Form 483, 2020-02-03
June, 2018 EIR Charles River Laboratories, Inc - EIR, 2018-06-15
July, 2010 FDA 483 Charles River Laboratories Cleveland, Inc. - Form 483, 2010-07-16
October, 2012 FDA 483 Response Battelle Memorial Institute - Form 483R, 2012-10-24
December, 2019 FDA 483 Vimta Labs Limited - Form 483, 2019-12-18
July, 2015 FDA 483 Covance Pharmaceutical R&D (Shanghai) Co - Form 483, 2015-07-24
October, 2014 EIR Charles River Laboratories - EIR, 2014-10-10
May, 2015 FDA 483 Colorado Histo-Prep - Form 483, 2015-05-19
May, 2013 FDA 483 Hoffmann La Roche Inc - Form 483, 2013-05-09
March, 2018 EIR Citoxlab North America Inc - EIR, 2018-03-02
September, 2014 EIR AbbVie Inc. - EIR, 2014-09-12
September, 2019 EIR Lovelace Biomedical Research Institute - EIR, 2019-09-13
February, 2012 FDA 483 Response SRI International - Form 483R, 2012-03-05
March, 2019 FDA 483 JOINN Laboratories (Suzhou) - Form 483, 2019-03-15
May, 2011 FDA 483 U.S. Army Medical Research Institute of Infectious Diseases - Form 483, 2011-05-10
May, 2019 FDA 483 Pharmaron - Form 483, 2019-05-24
August, 2017 FDA 483 Oeyama-Moto-Medical Group Foundation, LLC - Form 483, 2017-08-11
March, 2019 FDA 483 Wuxi Apptec Suzhou Co.,Ltd - Form 483, 2019-03-08
July, 2013 EIR Charles River Laboratories, Inc. - EIR, 2013-07-12
August, 2009 FDA 483 Response Frontage Laboratories, Inc. - Form 483R, 2009-09-04
April, 2009 FDA 483 BASI Gaithersburg, LLC - Form 483, 2009-04-22
October, 2012 FDA 483 Battelle Memorial Institute - Form 483, 2012-10-17
August, 2018 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2018-08-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more